«No hay suficiente investigación y el apoyo de cigarrillo electrónico». «Las búsquedas son pocas, y no es capaz de demostrar nada». «Sólo en treinta años usted tendrá una cierta evaluación de impacto del ecig la salud «. ¿Cuántas veces has escuchado estas declaraciones para justificar una falta de interés por los cigarrillos electrónicos. Pues bien, a partir de ahora no habrá más excusas que mantener. Publicamos a continuación la lista de la investigación científica en apoyo del cigarrillo electrónico (glicol, glicerina, nicotina) y en el daño cigarrillos tradicionales (ardor, tabaco) publicado hasta la fecha. Un paciente trabajo de recuperación de los datos a partir de los años 80. Contamos con 186 y, como una demostración de lo que decimos, para publicar uno por uno. En la primera columna la numeración de cada estudio, en el segundo año de publicación, mientras que el tercer título de la investigación realizada por los autores y, cuando sea posible, un enlace al documento original. Buena lectura!
| 1 | 2015 | Schweitzer KS, Chen SX, Law S, et al. (2015) – Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. – American Journal of Physiology (2015) Information: Authors exposed cells with plasma nicotine levels between 162.000 and 3,240.000 ng/ml and call this “relatively high” Funny fact: Lethal levels are between 2.000 and 4.000 ng/ml! Normal levels for smokers/vapers are between 20-30 ng/ml! (HT Bernd Mayer!) |
| 2 | 2015 | Tierney PA, Karpinski CD, Brown JE, et al. (2015) – Flavour chemicals in electronic cigarette fluids. – Tobacco Control (2015)) Commentary by Michael Siegel:: Study produces unwarranted scare |
| 3 | 2015 | Neilson L, Mankus C, Throne D, et al. (2015) – Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol. – Toxicology in Vitro (2015) |
| 4 | 2015 | Polosa R. (2015) – Electronic cigarette use and harm reversal: emerging evidence in the lung. – BMC Medicine (2015) |
| 5 | 2015 | Perkins KA, Karelitz JL, Michael VC (2015) – Reinforcement enhancing effects of acute nicotine via electronic cigarettes. – Drug Alcohol Dependence (2015) |
| 6 | 2015 | O’Connell G, Colard S, Cahours X, Prtchard (2015) – An Assessment of Indoor Air Quality before, during and after Unrestricted Use of E-Cigarettes in a Small Room. Int. Journal Research & PH (2015) |
| 7 | 2015 | Farsalinos KE, Voudris V, Poulas K (2015) – E-cigarettes generate high levels of aldehydes only in ‘dry puff’ conditions. Addiction (2015) Commentary by J-F Etter:: The recent scares were without substance, and the general verdict that e-cigs areat least 95% safer than smoking remains solid. |
| 8 | 2015 | Etter J-F (2015) – E-cigarettes: methodological and ideological issues and research priorities. – BMC Medicine (2015)) |
| 9 | 2015 | Cobb CO, Hendricks PS, Eissenberg T (2015) – Electronic cigarettes and nicotine dependence: evolving products, evolving problems. – BMC Medicine (2015) |
| 10 | 2015 | Farsalinos KE, Gillmann IG et al. (2015) – Nicotine Levels and Presence of Selected Tobacco-Derived Toxins in Tobacco Flavoured Electronic Cigarette Refill Liquids. – Int. Journal Environment Research & PH (2015) |
| 11 | 2015 | Varlet V, Farsalinos KE, Augsburger M (2015) – Toxicity Assessment of Refill Liquids for Electronic Cigarettes. – In. Journal Environment Research & PH (2015) |
| 12 | 2015 | Amato MS, Boyle RG, Levy D (2015) – How to define e-cigarette prevalence? Finding clues in the use frequency distribution. – Tobacco Control (2015) |
| 13 | 2015 | Hajek P (2015) – The development and testing of new nicotine replacement treatments: from ‘nicotine replacement’ to ‘smoking replacement’. Addiction (2015) |
| 14 | 2015 | Scheffler S, Dieken H, Krischenowski O, et al. (2015) – Evaluation of E-Cigarette Liquid Vapor and Mainstream Cigarette Smoke after Direct Exposure of Primary Human Bronchial Epithelial Cells. Int. J. Environ. Res. Public Health (2015) Information: Authors apparently ignored ISO 10993-5. They exposed NHBE cells with 200 puffs of e-cig aersol to generate a response. This means: They exposed the cells to as much aersol as needed to have toxicity. With this methodology, any chemical would be toxic. (HT Konstantinos Farsalinos!) |
| 15 | 2015 | O’Brien B, Knight-West O, Walker N, et al. (2015) – E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tobacco Induced Diseases (2015) |
| 16 | 2015 | Farsalinos K, Voudris V, Poulas K (2015) – Are Metals Emitted from Electronic Cigarettes a Reason for Health Concern? A Risk-Assessment Analysis of Currently Available Literature.. Int. Journal Environment Research & PH (2015)) |
| 17 | 2015 | Tayyarah R, Long GA (2015) – Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. – Regulatory Toxicology and Pharmacology (2015) |
| 18 | 2015 | Talih S, Balhas Z, Salman R, et al. (2015) – „Direct Dripping“: A High-Temperature, High-Formaldehyde Emission Electronic Cigarette Use Method. – Nicotine Tobacco Research (2015) |
| 19 | 2015 | Tackett AP, Lechner WV, DeMond MG, et al. (2015) Biochemically verified smoking cessation and vaping beliefs among vape store customers. – Addiction (2015) |
| 20 | 2015 | Shiffman S et al. (2014) – The Impact of Flavor Descriptors on Nonsmoking Teens’ and Adult Smokers’ Interest in Electronic Cigarettes. – Nicotine and Tobacco Research (2015) |
| 21 | 2015 | Al-Delaimy WK, Myers MG, Leas EC, et al. (2015) – E-Cigarette Use in the Past and Quitting Behavior in the Future: A Population-Based Study. – American Journal of Public Health (2015) |
| 22 | 2015 | Moore G, Hewitt G, Evans J, et al. (2015) – Electronic-cigarette use among young people in Wales: evidence from two cross-sectional surveys. – BMJ Open (2015) |
| 23 | 2015 | Etter J-F, Eissenberg T (2015) – Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes. – Drug and Alcohol Dependence (2015) |
| 24 | 2015 | Meier E M et al. (2015) – Which Nicotine Products Are Gateways to Regular Use?– American Journal of Preventive Medicine (2015) |
| 25 | 2015 | Mishra A, Chatuvedi P, Datta S, et al. (2015) – Harmful effects of nicotine. – Indian Journal Medicine Paediatric Oncology (2015) |
| 26 | 2014 | Rooke C, Cunningham-Burley S, Amos A (2014) – Smokers’ and ex-smokers’ understanding of electronic cigarettes: a qualitative study. – Tobacco Control (2014) |
| 27 | 2014 | Brown J, Beard E, Kotz D, Michie S, West R (2014) – Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. – Addiction (2014) |
| 28 | 2014 | Misra M, Leverette RD, Cooper BT, et al. (2014) – Comparative In Vitro Toxicity Profile of Electronic and Tobacco Cigarettes, Smokeless Tobacco and Nicotine Replacement Therapy Products: E-Liquids, Extracts and Collected Aerosols. – Int. Journal Research & PH (2014) |
| 29 | 2014 | Tierney PA, Karpinski CD, Brown JE et al. (2014) – Flavour chemicals in electronic cigarette fluids. – Tobacco Control (2014) |
| 30 | 2014 | Pepper JK, Ribisl KM, Emery SL, Brewer NT (2014) – Reasons for starting and stopping electronic cigarette use. – Int. Journal Research & PH (2014) |
| 31 | 2014 | Evans SE, Hoffman AC (2014) – Electronic cigarettes: abuse liability, topography and subjective effects. – Tobacco Control (2014) |
| 32 | 2014 | McNeill A, Etter J-F, Farsalinos KE, Hajek P, et al. (2014) – A critique of a World Health Organizationcommissioned report and associated paper on electronic cigarettes. – Addiction (2014) |
| 33 | 2014 | Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H (2014) – Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. – Addiction (2014) |
| 34 | 2014 | Hajek P (2014) – Electronic cigarettes have a potential for huge public health benefit. – BMC Medicine (2014) |
| 35 | 2014 | Bekki K, Uchiyama S et al. (2014) – Carbonyl Compounds Generated from Electronic Cigarettes. – International Journal of Environmental Research and Public Health (2014) |
| 36 | 2014 | Foulds J, Veldheer S et al. (2014) – Development of a questionnaire to assess dependence on electronic cigarettes in a large sample of ex-smoking e-cig users – Nicotine and Tobacco Research (2014) |
| 37 | 2014 | McRobbie H, Bullen C et al. (2014) – Electronic cigarettes for smoking cessation and reduction – Cochrane Library (2014) |
| 38 | 2014 | Pepper J.K. et al. (2014) – Adolescent Males‘ Awareness of and Willingness to Try Electronic Cigarettes – Journal of Adolescent Health (2014) |
| 39 | 2014 | Goniewicz M L et al. (2014) – Rise in Electronic Cigarette Use Among Adolescents in Poland – Journal of Adolescent Health (2014) |
| 40 | 2014 | Krishnan-Sarin S et al (2014) E-cigarette Use Among High School and Middle School Adolescents in Connecticut – Nicotine and Tobacco Research (2014) |
| 41 | 2014 | Farsalinos K., Romagna G. et al. (2014) Characteristics, Perceived Side Effects and Benefits of Electronic Cigarette Use: A Worldwide Survey of More than 19,000 Consumers – Int. J. Environ. Res. Public Health (2014) |
| 42 | 2014 | Pepper J.K. et al. (2014) How U.S. Adults Find Out About Electronic Cigarettes: Implications for Public Health Messages – Nicotine and Tobacco Research (2014) |
| 43 | 2014 | Paradise J. (2014) Electronic Cigarettes: Smoke-Free Laws, Sale Restrictions, and the Public Health – American Journal of public health |
| 44 | 2014 | Marini et al. (2014), Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide – Toxicology and Applied Pharmacology |
| 45 | 2014 | Food and Drug Administration (FDA) (2014) E-Cigarettes: Impact on Individual and Population Health – Tobacco Control Volume 23, suppl 2 |
| 46 | 2014 | Stimson G. V. (2014) Public health leadership and electronic cigarette users – European Journal of Public Health |
| 47 | 2014 | Curry L. and Lee YO (2014) E-cigarettes made especially for inmates – Tobacco Control 2014 |
| 48 | 2014 | Chatham-Stephens K. et al. (2014) Notes from the Field: Calls to Poison Centers for Exposures to Electronic Cigarettes — United States, September 2010–February 2014 – Morbidity and Mortality Weekly Report (MMWR) April 4, 2014 / 63(13);292-293 |
| 49 | 2014 | Rodrigo Córdoba García (2014) El desafío de los cigarrillos electrónicos/The challenge of electronic cigarettes – Atención Primaria |
| 50 | 2014 | Nutt D.J.,· Phillips L.D., · Balfour D. et al. (2014) Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach – Eur Addict Res 2014;20:218–225 |
| 51 | 2014 | Dagaonkar R., Udwadia Z. (2014) Water Pipes and E-cigarettes : New Faces of an Ancient Enemy – Journal of the association of physicians of india vol 62 |
| 52 | 2014 | Brown J., West R. (2014) Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers – Addictive Behaviors |
| 53 | 2014 | Cummings, K. et al. (2014) E-Cigarettes and Cancer Patients – Journal of Thoracic Oncology |
| 54 | 2014 | Shawna L. Carroll Chapman, Li-Tzy Wua (2014) – E-cigarette prevalence and correlates of use among adolescents versus adults: A review and comparison – Journal of Psychiatric Research |
| 55 | 2014 | Kim A. et al. (2014) E-cigarette Advertising Expenditures in the U.S., 2011–2012 – American Journal of Preventive Medicine |
| 56 | 2014 | Saitta, D., Ferro, G. and Polosa, R. (2014) Achieving appropriate regulations for electronic cigarettes. Ther Adv Chronic Dis 3 February 2014 (Epub ahead of print). DOI: 10.1177/2040622314521271 |
| 57 | 2014 | Farsalinos K., Stimsonb G. (2014), Is there any legal and scientific basis for classifying electronic cigarettes as medications ? – International Journal of Drug Policy |
| 58 | 2014 | Kubica P. , Wasik A., Kot-Wasik A. and Namieśnik J. (2014) – An evaluation of sucrose as a possible contaminant in e-liquids for electronic cigarettes by hydrophilic interaction liquid chromatography–tandem mass spectrometry – Analytical and Bioanalytical Chemistry |
| 59 | 2014 | Vallée JP., Gallois P., Le Noc Y. (2014) e-cigarette: vapoter vaut-il mieux que fumer ? – Médecine. Volume 10, Numéro 3, 121-6, Mars 2014, Stratégies |
| 60 | 2014 | Leverette R.D., Misra, M., Cooper, B;T. and Bennett, M.B. (2014) Potential toxicity of electronic cigarette liquids and aerosols as measured by four in vitro assays – 53rd Annual Meeting of the Society of Toxicology; Phoenix, AZ. |
| 61 | 2014 | Carlos A. et al. (2014) The Electronic Cigarette. Official Statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the Efficacy, Safety and Regulation of Electronic Cigarettes – Archivos de Bronconeumología |
| 62 | 2014 | Faure S., Babin S. et al. (2014) Managing tobacco addiction – Actualités Pharmaceutiques Volume 53, Issue 535, April 2014, Pages 27–30 |
| 63 | 2014 | Nelson N. (2014) More Questions Than Answers Surrounding E-Cigarette Debate JNCI J Natl Cancer Inst dju101 doi:10.1093/jnci/dju101 first published online March 31, 2014 |
| 64 | 2014 | Alpert HR, Agaku IT, Connolly GN (2015) – A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction. Tobacco Control (2014) |
| 65 | 2014 | Al-Abed A.; Chung T. et al. (2014) Perceptions, and Awareness of Electronic Cigarettes Among Healthcare Providers and In-Patients – 19th Denman Undergraduate Research Forum |
| 66 | 2014 | Hughes K., Hardcastle K. et al. (2014) “Most people I know have got one”: Young people’s perceptions and experiences of electronic cigarettes – Centre for Public Health, Liverpool John Moores University |
| 67 | 2014 | Hughes K., Hardcastle K. et al. (2014) E-cigarette access among young people in Cheshire and Merseyside Findings from the 2013 North West Trading Standards survey – Centre for Public Health, Liverpool John Moores University |
| 68 | 2014 | Sochor O. et al. (2014) Tobacco use and some characteristics of tobacco users. Preliminary results of “Kardiovize Brno 2030” Cor et Vasa |
| 69 | 2014 | Farsalinos K., Polosa R. (2014) – Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. – Therapeutic Advances in Drug Safety (2014) |
| 70 | 2014 | Behar, R., Davis, B., Wang, Y., Bahl, V., Lin, S. and Talbot, P. (2014) Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro 28: 198–208. |
| 71 | 2014 | Burstyn, I. (2014) Peering through the mist: Systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks.BMC Public Health (2013) |
| 72 | 2014 | Farsalinos, K., Spyrou, A., Tsimopoulou, K., Stefopoulos, C., Romagna, G. and Voudris, V. (2014). Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep (in press). |
| 73 | 2014 | Grana R.A., Popova L., Ling P.M. (2014) A Longitudinal Analysis of Electronic Cigarette Use and Smoking Cessation JAMA Intern Med |
| 74 | 2014 | Nides, M., Leischow, S., Bhatter, M. and Simmons, M. (2014) Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav 38: 265–274. |
| 75 | 2013 | Ronk CJ, Hollins DM, Jacobsen DM (2013) – Evaluation of pulmonary function within a cohort of flavorings workers. – Inhal Toxicol. (2013) – Important!!! |
| 76 | 2013 | Dautzenberg B et al. (2013) – E-Cigarette: A New Tobacco Product for Schoolchildren in Paris – Open Journal of Respiratory Diseases (2013) |
| 77 | 2013 | Adkison, S., O’Connor, R., Bansal-Travers, M., Hyland, A., Borland, R., Yong, H.H. et al. (2013) Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 44: 207–215. |
| 78 | 2013 | Barnoya, J. and Navas-Acien, A. (2013) Protecting the world from secondhand tobacco smoke exposure: where do we stand and where do we go from here? Nicotine Tob Res 15: 789–804. |
| 79 | 2013 | Bertholon, J., Becquemin, M., Roy, M., Roy, F., Ledur, D., Annesi Maesano, I. et al. (2013) Comparison of the aerosol produced by electronic cigarettes with conventional cigarettes and the shisha. Rev Mal Respir 30: 752–757. |
| 80 | 2013 | Bullen, C., Howe, C., Laugesen, M., McRobbie, H., Parag, V., Williman, J. et al. (2013) Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382: 1629–1637. |
| 81 | 2013 | Camenga, D., Delmerico, J., Kong, G., Cavallo, D., Hyland, A., Cummings, K. et al. (2013) Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav 39(1): 338–340. Cantrell, F. (2013) Adverse effects of e-cigarette exposures. J Community Health 15 December 2013 (Epub ahead of print). DOI: 10.1007/s10900-013- 9807-5 |
| 82 | 2013 | Caponnetto, P., Auditore, R., Russo, C., Cappello, G. and Polosa, R. (2013a) Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 10: 446–461. |
| 83 | 2013 | Caponnetto, P., Campagna, D., Cibella, F., Morjaria, J., Caruso, M., Russo, C. et al. (2013b) EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 8: e66317. |
| 84 | 2013 | Centers for Disease Control and Prevention (CDC) (2013) Notes from the field: electronic cigarette use among middle and high school students – United States, 2011-2012. MMWR Morb Mortal Wkly Rep 62: 729–730. Chen, I. (2013) FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res 15: 615–616. |
| 85 | 2013 | Czogala, J., Goniewicz, M., Fidelus, B., Zielinska- Danch, W., Travers, M. and Sobczak, A. (2013) Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res (11 December 2011 (Epub ahead of print). DOI: 10.1093/ntr/ntt203 |
| 86 | 2013 | Dawkins, L. (2013) Electronic cigarettes: what are they and are they effective? E-Cigarette Summit, London, UK (oral presentation). Available at: http://e-cigarettesummit. com/wp-content/uploads/2013/12/Summit- Presentations.pdf [accessed 22 December 2013]. |
| 87 | 2013 | Dawkins, L. and Corcoran, O. (2013) Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 231: 401–407. |
| 88 | 2013 | Dawkins, L., Turnern, J., Roberts, A. and Soar, K. (2013) ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction 108: 1115–1125. |
| 89 | 2013 | Dockrell, M., Morison, R., Bauld, L. and McNeill, A. (2013) E-Cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 15: 1737–1744. |
| 90 | 2013 | Douptcheva, N., Gmel, G., Studer, J., Deline, S. and Etter, J.F. (2013) Use of electronic cigarettes among young Swiss men. J Epidemiol Community Health 67: 1075–1076. |
| 91 | 2013 | Etter, J., Zäther, E. and Svensson, S. (2013) Analysis of refill liquids for electronic cigarettes. Addiction 108: 1671–1679. |
| 92 | 2013 | Farsalinos, K. and Romagna, G. (2013) Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep 6: 15–21. |
| 93 | 2013 | Farsalinos, K., Romagna, G., Allifranchini, E., Ripamonti, E., Bocchietto, E., Todeschi, S. et al. (2013a) Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 10: 5146–5162. |
| 94 | 2013 | Farsalinos, K., Romagna, G., Tsiapras, D., Kyrzopoulos, S. and Voudris, V. (2013b) Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 7: 139–146. |
| 95 | 2013 | Farsalinos, K., Romagna, G., Tsiapras, D., Kyrzopoulos, S. and Voudris, V. (2013c)Evaluation of electronic cigarette use topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities’ regulation. Int J Environ Res |
| 96 | 2013 | Farsalinos, K., Romagna, G. and Voudris, V. (2013d) Authors miss the opportunity to discuss important public health implications. J Chromatogr A 1312: 155–156. |
| 97 | 2013 | Farsalinos, K., Tsiapras, D., Kyrzopoulos, S., Stefopoulos, C., Spyrou, A., Tsakalou, M. et al. (2013f) Immediate effects of electronic cigarette use on coronary circulation and blood carboxyhemoglobin levels: comparison with cigarette smoking. Eur Heart J 34(Abstract Supplement): 13. |
| 98 | 2013 | Flouris, A., Chorti, M., Poulianiti, K., Jamurtas, A., Kostikas, K., Tzatzarakis, M. et al. (2013) Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25: 91–101. |
| 99 | 2013 | Goniewicz, M., Knysak, J., Gawron, M., Kosmider, L., Sobczak, A., Kurek, J. et al. (2013) Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. DOI: 10.1136/ tobaccocontrol-2012-050859. (Published online: 6 March 2013). |
| 100 | 2013 | Kim, H. and Shin, H. (2013) Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatographytandem mass spectrometry. J Chromatogr A 1291: 48–55. |
| 101 | 2013 | King, B., Alam, S., Promoff, G., Arrazola, R. and Dube, S. (2013) Awareness and ever use of electronic cigarettes among US adults, 2010–2011. Nicotine Tob Res 15(9): 1623–1627. |
| 102 | 2013 | Lee, S., Grana, R. and Glantz, S. (2013) Electronic cigarette use among Korean adolescents: a crosssectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health (2013) |
| 103 | 2013 | Mayer, B. (2013). How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century.. Arch Toxicol 88: 5–7. |
| 104 | 2013 | MHRA Commission on human medicines, Working Group on nicotine containing products (NCPS) (2013). Current use of electronic cigarettes. |
| 105 | 2013 | National Association of Attorneys General (2013) FDA regulation on E-cigarettes. Available at: http:// www.naag.org/assets/files/pdf/E%20Cigarette%20 Final%20Letter%20(5)(1).pdf (Accessed: 20 November 2013). |
| 106 | 2013 | Nielsen, S., Franklin, G., Longstreth, W., Swanson, P. and Checkoway, H. (2013) Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol 74: 472–477. |
| 107 | 2013 | Palamidas, A., Gennimata, S., Kaltsakas, G., Tsikrika, S., Vakali, S., Gratziou, C. et al. (2013) Poster: Acute effect of an e-cigarette with and without nicotine on lung function. |
| 108 | 2013 | Polosa, R. and Caponnetto, P. (2013) Time for evidence-based e-cigarette regulation. Lancet Oncol (2013) |
| 109 | 2013 | Polosa, R., Morjaria, J., Caponnetto, P., Campagna, D., Russo, C., Alamo, A. et al. (2013a) Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. DOI: 10.1007/s11739-013-0977-z (Published online: July 2013). |
| 110 | 2013 | Polosa, R., Rodu, B., Caponnetto, P., Maglia, M. and Raciti, C. (2013b) A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 10: 19. |
| 111 | 2013 | Romagna, G., Allifranchini, E., Bocchietto, E., Todeschi, S., Esposito, M. and Farsalinos, K. (2013) Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 25: 354–361. |
| 112 | 2013 | SRNT Europe Annual Congress, Helsinki, Finland. Poster RRP18. Available at: http://www.srnteurope. org/assets/srnt-e2012abstractbook.pdf [accessed 20 November 2013]. |
| 113 | 2013 | Schober, W., Szendrei, K., Matzen, W., Osiander- Fuchs, H., Heitmann, D., Schettgen, T. et al. (2013) Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health. DOI: 10.1016/j.ijheh.2013.11.003. (Published online: 6 December 2013). |
| 114 | 2013 | Schripp, T., Markewitz, D., Uhde, E. and Salthammer, T. (2013) Does e-cigarette consumption cause passive vaping? Indoor Air 23: 25–31. |
| 115 | 2013 | US Pharmacopeia (2013) Elemental impurities limits. Available at: http://www.usp.org/sites/default/files/usp_ pdf/EN/USPNF/key-issues/c232_final.pdf (Accessed: 20 November 2013). |
| 116 | 2013 | Van Staden, S., Groenewald, M., Engelbrecht, R., Becker, P. and Hazelhurst, L. (2013) Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S Afr Med J 103: 865–868. |
| 117 | 2013 | Williams, M., Villarreal, A., Bozhilov, K., Lin, S. and Talbot, P. (2013) Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 8: e57987. |
| 118 | 2013 | World Health Organization (2013) Tobacco fact sheet No 339. Updated July 2013. Available at: http://www. who.int/mediacentre/factsheets/fs339/en/ (Accessed: 18 November 2013). |
| 119 | 2012 | Goniewicz M L et al. (2012) – Electronic Cigarette Use Among Teenagers and Young Adults in Poland – Pediatrics (2012) |
| 120 | 2012 | Aubin, H., Rollema, H., Svensson, T. and Winterer, G. (2012) Smoking, quitting, and psychiatric disease: A review. Neurosci Biobehav Rev 36: 271–284. |
| 121 | 2012 | Bahl, V., Lin, S., Xu, N., Davis, B., Wang, Y. and Talbot, P. (2012) Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 34: 529–537. |
| 122 | 2012 | Farsalinos, K., Tsiapras, D., Kyrzopoulos, S., Savvopoulou, M., Avramidou, E., Vasilopoulou, D. et al. (2012) Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. Eur Heart J 33(Abstract Supplement): 203. |
| 123 | 2012 | Flouris, A., Poulianiti, K., Chorti, M., Jamurtas, A., Kouretas, D., Owolabi, E. et al. (2012) Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 50: 3600–3603. |
| 124 | 2012 | Gennimata, S., Palamidas, A., Kaltsakas, G., Tsikrika, S., Vakali, S., Gratziou, C. et al. (2012) Acute effect of e-cigarette on pulmonary function in healthy subjects and smokers. Presented at the European Respiratory Society’s Annual Congress, Poster P1053. Available at: https://www.ersnetsecure.org/public/prg_congres. abstract?ww_i_presentation=59718 (Accessed: 20 November 2013). |
| 125 | 2012 | McAuley, T., Hopke, P., Zhao, J. and Babaian, S. (2012) Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 24: 850–857. McCauley, L., Markin, C. and Hosmer, D. (2012) An unexpected consequence of electronic cigarette use. Chest 141(4): 1110–1113. |
| 126 | 2012 | Pellegrino, R., Tinghino, B., Mangiaracina, G., Marani, A., Vitali, M., Protano, C. et al. (2012) Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 24: 279–288. |
| 127 | 2012 | Romagna, G., Zabarini, L., Barbiero, L., Bocchietto, E., Todeschi, S., Caravati, E. et al. (2012) Characterization of chemicals released to the environment by electronic cigarettes use (ClearStream-Air project): is passive vaping a reality? TAW524430.indd 19 11/02/2014 6:10:34 PM by fila olivier Downloaded from taw.sagepub.com on February 14, 2014 Therapeutic Advances in Drug Safety 20 http://taw.sagepub.com |
| 128 | 2012 | US Fire Administration (2012) Smoking-related Fires in residential buildings (2008-2010). Topical Fire Report Series 13. Available at: http://www.usfa.fema. gov/downloads/pdf/statistics/v13i6.pdf (Accessed: 20 November 2013). |
| 129 | 2012 | Vardavas, C., Anagnostopoulos, N., Kougias, M., Evangelopoulou, V., Connolly, G. and Behrakis, P. (2012) Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 141: 1400–1406. |
| 130 | 2012 | Woolf, K., Zabad, M., Post, J., McNitt, S., Williams, G. and Bisognano, J. (2012) Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. Am J Cardiol 110: 968–970. |
| 131 | 2011 | Cahn, Z. and Siegel, M. (2011) Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 32: 16–31. |
| 132 | 2011 | Caponnetto, P., Polosa, R., Auditore, R., Russo, C. and Campagna, D. (2011a) Smoking cessation with e-cigarettes in smokers with a documented history of depression and recurring relapses. Int J Clin Med 2: 281–284. |
| 133 | 2011 | Caponnetto, P., Polosa, R., Russo, C., Leotta, C. and Campagna, D. (2011b) Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep 5: 585. |
| 134 | 2011 | Etter, J. and Bullen, C. (2011) Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 106: 2017–2028. |
| 135 | 2011 | Lotfipour, S., Arnold, M., Hogenkamp, D., Gee, K., Belluzzi, J. and Leslie, F. (2011) The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. Neuropharmacology 61: 95–104. |
| 136 | 2011 | Polosa, R., Caponnetto, P., Morjaria, J., Papale, G., Campagna, D. and Russo, C. (2011) Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 11: 786. |
| 137 | 2011 | Werley, M., McDonald, P., Lilly, P., Kirkpatrick, D., Wallery, J., Byron, P. et al. (2011) Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology 287: 76–90. |
| 138 | 2010 | Hadwiger, M., Trehy, M., Ye, W., Moore, T., Allgire, J. and Westenberger, B. (2010) Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 1217: 7547–7555. |
| 139 | 2010 | Riess, U., Tegtbur, U., Fauck, C., Fuhrmann, F., Markewitz, D. and Salthammer, T. (2010) Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath. Anal Chim Acta 669: 53–62. |
| 140 | 2010 | Rigotti, N., Pipe, A., Benowitz, N., Arteaga, C., Garza, D. and Tonstad, S. (2010) Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial. Circulation 121: 221–229. |
| 141 | 2009 | Food and Drug Administration (2009) FDA and Public health experts warn about electronic cigarettes. Available at: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm173222.htm (Accessed: 20 November 2013). |
| 142 | 2009 | Laugesen, M. (2009). Ruyan®E-cigarette Bench-top tests. Society for Research on Nicotine and Tobacco (SRNT) Dublin, Poster 5-11. Available at: http:// www.healthnz.co.nz/DublinEcigBenchtopHandout. pdf [accessed 20 November 2013]. Le Houezec, J., McNeill, A. and Britton, J. (2011) Tobacco, nicotine and harm reduction. Drug Alcohol Rev 30: 119–123. |
| 143 | 2009 | Mayers, M. (2009) FDA acts to protect public health from electronic cigarettes. Campaign for Tobacco-Free Kids statement. Available at: http:// www.tobaccofreekids.org/press_releases/post/id_1166 (Accessed: 20 November 2013). |
| 144 | 2009 | Moore, D., Aveyard, P., Connock, M., Wang, D., Fry-Smith, A. and Barton, P. (2009) Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 338: b1024. |
| 145 | 2009 | Westenberger, B. (2009) Evaluation of e-Cigarettes. St.Louis, MO: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis. Available at: http://www.fda. gov/downloads/drugs/Scienceresearch/UCM173250. pdf (Accessed: November 10, 2013). |
| 146 | 2008 | Laugesen, M. (2008) Safety Report on the Ruyan® e-cigarette Cartridge and Inhaled Aerosol. Available at: http://www.healthnz.co.nz/ RuyanCartridgeReport30-Oct-08.pdf (Accessed: 18 November 2013). |
| 147 | 2008 | Ravindra, K., Wauters, E. and Van Grieken, R. (2008) Variation in particulate PAHs levels and their relation with the transboundary movement of the air masses. Sci Total Environ 396: 100–110. |
| 148 | 2006 | McClernon, F., Hiott, F., Westman, E., Rose, J. and Levin, E. (2006) Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) 189: 125–133. |
| 149 | 2006 | Rodu, B. and Godshall, W. (2006) Tobacco harm reduction: An alternative cessation strategy for inveterate smokers. Harm Reduct J 3: 37. |
| 150 | 2006 | Rose, J. (2006) Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl) 184: 274–285. |
| 151 | 2006 | Schiller, J. and Ni, H. (2006) Cigarette smoking and smoking cessation among persons with chronic obstructive pulmonary disease. Am J Health Promot 20: 319–323. |
| 152 | 2005 | Hukkanen J, Jacob P III, Benowitz N L (2005) – Metabolism and Disposition Kinetics of Nicotine – Pharmacological Reviews (2005) |
| 153 | 2005 | De Leon, J. and Diaz, F. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76: 1351–1357. |
| 154 | 2005 | Guillem, K., Vouillac, C., Azar, M., Parsons, L., Koob, G., Cador, M. et al. (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25: 8593–8600. |
| 155 | 2005 | Hubbard, R., Lewis, S., Smith, C., Godfrey, C., Smeeth, L., Farrington, P. et al. (2005) Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 14: 416–421. |
| 156 | 2005 | Peters, A. (2005) Particulate matter and heart disease: evidence from epidemiological studies. Toxicol Appl Pharmacol 207: 477–482. |
| 157 | 2005 | Varughese, S., Teschke, K., Brauer, M., Chow, Y., van Netten, C. and Kennedy, S. (2005) Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am J Ind Med 47: 411–418. |
| 158 | 2004 | Ambrose, J. and Barua, R. (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43: 1731–1737. |
| 159 | 2004 | WHO-IARC (2004) IARC monographs on the evaluation of carcinogenic risks to humans. Volume 83, tobacco smoke and involuntary smoking. Available at: http://monographs.iarc.fr/ENG/Monographs/vol83/ mono83.pdf. (Accessed: 20 November 2013). |
| 160 | 2003 | American Chemistry Council (2003) Ethylene Glycols: Considerations Against Use in Theatrical Fogs/Mist and Artificial Smoke. Available at: http:// www.americanchemistry.com/ProductsTechnology/ Ethylene-Glycols-2/PDF-Ethylene-Glycols-Fog- Information-Sheet.pdf (Accessed: 20 November 2013). |
| 161 | 2003 | Yudkin, P., Hey, K., Roberts, S., Welch, S., Murphy, M. and Walton, R. (2003) Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 327: 28–29. |
| 162 | 2002 | Czekaj, P., Pałasz, A., Lebda-Wyborny, T., Nowaczyk- Dura, G., Karczewska, W., Florek, E. et al. (2002) Morphological changes in lungs, placenta, liver and kidneys of pregnant rats exposed to cigarette smoke. Int Arch Occup Environ Health 75 (Suppl): S27–S35. |
| 163 | 2001 | Wieslander, G., Norbäck, D. and Lindgren, T. (2001) Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 58: 649–655. |
| 164 | 2000 | Moline JM, Golden AL, Highland JH, Wilmarth KR & Kao AS (2000) – Health effects evaluation of theatrical smoke, haze and pyrotechnics. |
| 165 | 2000 | Brown, S., Inskip, H. and Barraclough, B. (2000) Causes of the excess mortality of schizophrenia. Br J Psychiatry 177: 212–217 |
| 166 | 2000 | Environmental Protection Agency (2000) Cinnamaldehyde (040506) fact sheet. Available at: http://www.epa.gov/pesticides/chem_search/ reg_actions/registration/fs_PC-040506_1-Oct-98.pdf (Accessed: 20 November 2013). |
| 167 | 1999 | Guslandi, M. (1999) Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol 48: 481–484. |
| 168 | 1999 | Lúdvíksdóttir, D., Blöndal, T., Franzon, M., Gudmundsson, T. and Säwe, U. (1999) Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med 246: 61–66. |
| 169 | 1999 | Nitenberg, A. and Antony, I. (1999) Effects of nicotine gum on coronary vasomotor responses during sympathetic stimulation in patients with coronary artery stenosis. J Cardiovasc Pharmacol 34: 694–699. |
| 170 | 1998 | Benowitz, N., Zevin, S. and Jacob, P. III (1998) Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther 287: 958–962. |
| 171 | 1998 | Greenland, S., Satterfield, M. and Lanes, S. (1998) A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety 18: 297–308. |
| 172 | 1998 | Zevin, S., Benowitz, N. and Jacob, P. (1998) Doserelated cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther 64: 87–95. |
| 173 | 1997 | Benowitz N L, Zevin S, Jacob P III (1997) – Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking – British Journal of Clinical Pharmacology (1997) |
| 174 | 1997 | Benowitz, N. and Gourlay, S. (1997) Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29: 1422– 1431. |
| 175 | 1996 | Murray, R., Bailey, W., Daniels, K., Bjornson, W., Kurnow, K., Connett, J. et al. (1996) Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 109: 438–445. |
| 176 | 1995 | Seaton, A., MacNee, W., Donaldson, K. and Godden, D. (1995) Particulate air pollution and acute health effects. Lancet 345: 176-178. |
| 177 | 1993 | Pryor, W. and Stone, K. (1993) Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 686: 12–28. |
| 178 | 1992 | Environmental Protection Agency (1992) EPA Report/600/6-90/006F. Respiratory health effects of passive smoking: lung cancer and other disorders. Washington, DC. Available at: http://oaspub.epa. gov/eims/eimscomm.getfile?p_download_id=36793 (Accessed: 20 November 2013). |
| 179 | 1992 | Renne, R., Wehner, A., Greenspan, B., Deford, H., Ragan, H., Westenberg, R. et al. (1992) 2-Week and 13-Week Inhalation Studies of Aerosolized Glycerol in Rats. Inhal Toxicol 4: 95–111. |
| 180 | 1991 | Rose, J. and Levin, E. (1991) Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict 86: 605–609. |
| 181 | 1991 | Russell, M. (1991) The future of nicotine replacement. Br J Addict 86: 653–658. |
| 182 | 1989 | Hajek, P., Jarvis, M., Belcher, M., Sutherland, G. and Feyerabend, C. (1989) Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebocontrolled study. Psychopharmacology (Berl) 97: 99–102. |
| 183 | 1989 | Sahakian, B., Jones, G., Levy, R., Gray, J. and Warburton, D.(1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797–800. |
| 184 | 1987 | Benowitz N L et al. (1987) – Prolonged absorption with development of tolerance to toxic effects after cutaneous exposure to nicotine – Clinical Pharmacology & Therapeutics (1987) |
| 185 | 1985 | Antal, M., Mok, W., Roy, J. and T-Raissi, A. (1985) Pyrolytic sources of hydrocarbons from biomass. J Anal Appl Pyrol 8: 291–303. |
| 186 | 1983 | Stein, Y., Antal, M. and Jones, M. (1983) A study of the gas-phase pyrolysis of glycerol. J Anal Appl Pyrol 4: 283–296. |
Un agradecimiento especial para el amigo Rursus por su brillante idea.
Tomado de: http://www.sigmagazine.it
Esta es una traducción automatizada. El administrador del sitio ha hecho algunos cambios en los textos para su mejor comprensión. Si tiene alguna sugerencia de cambio por favor háganosla saber.
